Skip to content
DataLookout
Menu

NCT07932054

Immune Reconstitution Characteristics and Influencing Factors Following Umbilical Cord Blood Transplantation

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

The quantity and diversity of immune cells
Timeframe: On post-transplant days 30 ± 3, 60 ± 3, 90 ± 3, 120 ± 3, 180 ± 7, 270 ± 7, and 360 ± 7

Secondary (6)

Incidence of engraftment syndrome
Incidence of infections
Incidence of relapse
Incidence of non-relapse mortality
Incidence of graft-versus-host disease
Show 1 moreShow less
survival

Sites

1 site in 1 country

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeTianjin, China